Literature DB >> 7841425

Why do our patients die of active tuberculosis in the era of effective therapy?

N Zafran1, E Heldal, S Pavlovic, D Vuckovic, J Boe.   

Abstract

SETTING: All patients with tuberculosis as a primary or underlying cause of death who were autopsied at the Institute for Lung Diseases and Tuberculosis, Sremska Kamenica, in the former Yugoslavia, between 1981 and 1990 were investigated.
OBJECTIVE: To study why people die of active tuberculosis in the era of effective chemotherapy and to identify factors contributing to death.
DESIGN: In a retrospective investigation, this index group was compared with a control group consisting of patients who suffered from tuberculosis over the same period but who improved and were discharged from hospital.
RESULTS: A significant difference in age (P < 0.05) was found between those patients who died with an antemortem-established diagnosis and those who died with unrecognised tuberculosis (median 49 and 60 years respectively). When it came to the index group, 28 patients (56%) had one or more risk factors and the frequency of alcohol abuse was significantly higher (P < 0.001). Antituberculosis treatment had been introduced in 27 cases (54%). The median duration of hospitalization before therapy was 2 days and the median duration of antituberculosis therapy was 7 days. Of the 23 untreated tuberculosis patients, 74% died within the first 4 days.
CONCLUSION: Delay in the detection of tuberculosis was the main factor contributing to death in our patients.

Entities:  

Mesh:

Year:  1994        PMID: 7841425     DOI: 10.1016/0962-8479(94)90077-9

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  5 in total

1.  Ciprofloxacin once daily versus twice daily for the treatment of pulmonary tuberculosis.

Authors:  H Bergstermann; A Rüchardt
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

2.  Treatment outcome of new culture positive pulmonary tuberculosis in Norway.

Authors:  Mohamed Guled Farah; Aage Tverdal; Tore W Steen; Einar Heldal; Arne B Brantsaeter; Gunnar Bjune
Journal:  BMC Public Health       Date:  2005-02-07       Impact factor: 3.295

3.  Tuberculosis mortality: patient characteristics and causes.

Authors:  Chou-Han Lin; Chou-Jui Lin; Yao-Wen Kuo; Jann-Yuan Wang; Chia-Lin Hsu; Jong-Min Chen; Wern-Cherng Cheng; Li-Na Lee
Journal:  BMC Infect Dis       Date:  2014-01-03       Impact factor: 3.090

4.  Patient and health system delay among patients with pulmonary tuberculosis in Beira city, Mozambique.

Authors:  Abuchahama Saifodine; Paula Samo Gudo; Mohsin Sidat; James Black
Journal:  BMC Public Health       Date:  2013-06-07       Impact factor: 3.295

5.  The delay in diagnosis of tuberculosis in the Monteregie region of Quebec, Canada.

Authors:  Caroline Lacroix; Philippe Martin; Sebastien Turcotte; Steven DeRoche; Vanessa Magluilo; Christine Lacroix
Journal:  Mcgill J Med       Date:  2008-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.